PACS — PACS Group Inc. stock price and chart

PACS

$47.72+4.08%

as of close, Oct 20, 2026

☾ AH $47.72 +4.08%

PACS Group Inc.Stock · HealthcareRussell 2000 · 0.06% of IWMUS Stock Market · 0.002% of VTIRussell 3000 · 0.002% of IWV

PeersENSGUHSEHCDVATHCSPY

Share this page

Technical analysis2

Overlay lines0

Addendum charts0

Available history since Apr 12, 2024

VolumeEEEE

202420252026

10.015.020.025.030.035.040.045.0010.0M$47.72

2026-10-20

Price$47.72

MA20$43.56

MA50$42.81

Vol1.4M

What would $1,000 invested in PACS be worth today? →

PACS returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $47.72
YTD price return: +24.30%
YTD total return: +24.30%
Next earnings: Nov 18, 2026
Market cap: 7.6B2024-06 4.5B2026-10 7.6B+68.1% over the window
Enterprise value: 10.8B
Shares outstanding: 158.3M2022-12 128.7M2026-06 158.3M+23.0% over the window
52W low: $10.31
52W high: $49.49
From 52W high: -3.58%
From 52W low: +362.85%
52W range: 95%

Volume

Rel volume: 1.01×
30D volume: 805.1K
30D $ vol: 35.1M

Fundamentals

Sales (ttm): 5.5B2022-12 2.4B2026-06 5.5B+131.3% over the window
Sales/share: $35.052022-12 $18.642026-06 $35.05+88.0% over the window
EPS (ttm): $1.742022-12 $1.172026-06 $1.74+48.6% over the window
FCF (ttm): 455.8M2022-12 69.8M2026-06 455.8M+553.4% over the window
FCF/share: $2.882022-12 $0.542026-06 $2.88+431.2% over the window
Book value/share: $7.012022-12 $0.532026-06 $7.01+1215.0% over the window
Net margin: 4.85%2022-12 6.3%2026-06 4.9%-22.7% over the window
ROE: 24.24%2022-12 219.2%2026-06 24.2%-88.9% over the window
ROA: 4.76%2023-12 3.2%2026-06 4.8%+48.1% over the window
Debt / equity: 0.21×2023-12 2.042026-06 0.21-89.4% over the window
Current ratio: 0.912023-12 1.582026-06 0.91-42.3% over the window

Growth (CAGR, ttm) · 10Y

Sales: +15.20%2025-06-30 → 2026-06-304.8B → 5.5B (+15.2% total)+27.11%2022-12-31 → 2026-06-302.4B → 5.5B (+131.3% total)n/an/a
Net income: +103.62%2025-06-30 → 2026-06-30132.3M → 269.2M (+103.5% total)+18.09%2022-12-31 → 2026-06-30150.5M → 269.2M (+78.9% total)n/an/a
FCF: +13.96%2025-06-30 → 2026-06-30400M → 455.8M (+14.0% total)+71.07%2022-12-31 → 2026-06-3069.8M → 455.8M (+553.4% total)n/an/a
Shares: +1.13%2025-06-30 → 2026-06-30156.6M → 158.3M (+1.1% total)+7.14%2023-06-30 → 2026-06-30128.7M → 158.3M (+23.0% total)n/an/a

Per-share growth (CAGR, ttm) · 10Y

EPS: +112.95%2025-06-30 → 2026-06-30$0.82 → $1.74 (+112.8% total)+12.00%2022-12-31 → 2026-06-30$1.17 → $1.74 (+48.6% total)n/an/a
Sales/share: +13.91%2025-06-30 → 2026-06-30$30.77 → $35.05 (+13.9% total)+19.80%2022-12-31 → 2026-06-30$18.64 → $35.05 (+88.0% total)n/an/a
FCF/share: +12.69%2025-06-30 → 2026-06-30$2.55 → $2.88 (+12.7% total)+61.23%2022-12-31 → 2026-06-30$0.54 → $2.88 (+431.2% total)n/an/a
Book value/share: +36.12%2025-06-30 → 2026-06-30$5.15 → $7.01 (+36.1% total)+120.87%2023-06-30 → 2026-06-30$0.65 → $7.01 (+978.0% total)n/an/a
Dividend/share: -83.04%2024-03-31 → 2025-03-31$0.62 → $0.10 (-83.0% total)n/an/an/a
Price: +276.68%2025-10-20 → 2026-10-20$12.68 → $47.72 (+276.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+33.53%2024-04-11 → 2026-10-20$23.00 → $47.72 (+107.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/an/a
Total return: +276.68%2025-10-20 → 2026-10-20$12.68 → $47.72 (+276.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+33.53%2024-04-11 → 2026-10-20$23.00 → $47.72 (+107.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/an/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 27.4×2024-06 40.842026-10 28.07-31.3% over the window
Fwd P/E: 17.0×
P/S (ttm)Market cap ÷ TTM revenue.: 1.4×2024-06 1.352026-10 1.36+0.6% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 6.8×2024-06 39.552026-10 6.80-82.8% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 16.6×2024-06 -603.542026-10 16.58-102.7% over the window
EV/EBITDA (fy): 26.3×
EV/Sales (ttm): 1.9×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 6.03%2024-03 -0.2%2026-06 6.8%-4174.4% over the window
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($7.6B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.00%2024-03 0.0%2026-06 0.0%
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($7.6B). Same caveat as the cash buyback yield.: 0.00%2024-03 1.8%2026-06 0.0%-100.0% over the window

Performance · price return · as of 2026-10-20#

+4.08%

+7.53%

+13.30%

+6.68%

YTD

+24.30%

+276.34%

—

Financial statements

Open full PACS financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+11.34%	+3.49%
JNJ	Johnson & Johnson	-3.94%	+2.19%
ABBV	AbbVie Inc.	+9.52%	+2.26%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+11.24%	+3.04%
MRK	Merck & Co. Inc.	+0.97%	+3.25%
NVS	Novartis AG	+9.45%	+2.29%
TMO	Thermo Fisher Scientific Inc.	+5.51%	+1.18%
AMGN	Amgen Inc.	+13.82%	+3.29%

PACS — PACS Group Inc. price, chart and key statistics